First Choice Research Centers Clinical Trials

First Choice Research Centers offer clinical trials for Alzheimer’s disease, Dementia, Parkinson’s disease and other neurological disorders.

clinical trials

First Choice Research Center 2 Clinical Trials

AD mission Study by Eisai

This is an oral BACE (beta-amyloid cleavage enzyme) inhibitor agent with a low side effect profile. Patients get a free amyloid PET CT during screening for this study. For MCI (mild cognitive impairment) and mild AD (Alzheimer’s disease) dementia patients. MMSE 24 and above. Top age is 85. Must be able to do an MRI brain. Informant/study partner needed.

 

Harmony Study by Acadia

This is a Nuplazid/Pimavanserin study for Dementia Patients with hallucinations and/or delusions ages 50-90. (Dementia-related Psychosis). ALL TYPES of Dementia are allowed and MRIs are not needed. Informant/study partner needed.

 

Periscope Study by Lilly

(LMDC trial) This is for Alzheimer’s disease and MCI patients. MMSE 22 and above. This is an infusion study with anti-TAU monoclonal Antibody. Patients will require TAU PET CT and MRI brain. Ages 60-85. Informant/study partner needed.

 

PRESENCE Study by Lilly

(HBEH trial). This is a Parkinson’s disease Dementia (PDD) Study. Ages 40-85. At least 2 years of Parkinson’s disease. Hoehn and Yahr Stages 1 to 4. This is a novel dopamine D1 receptor subtype (D1PAM) positive Dopamine allosteric modulator being tested to enhance cognition in PDD.